Pricing and Reimbursement

Just published is a new report entitled: Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value. The publication is a report of the 2016 ICER Membership Policy Summit.

This paper uses MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and then uses these preferences to assess the value of obinutuzumab for rituximab-refractory iNHL.

ISPOR’s 19th Annual European Congress is scheduled for 29 October – 2 November 2016 in Vienna. This post contains a summary of the contributions by various members of the OHE team.

The Nobel in Economics was awarded to Oliver Hart and Bengt Holmström for their research on Contract Theory. This blog reviews the contributions of contract theory to health economic issues.

OHE has just published two new briefings entitled ‘New Age Decision Making in HTA’ and ‘How Can HTA in Asia-Pacific Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?’. Both publications are reports of panel sessions held at the HTAi 2016 meeting in Tokyo.

The biannual EuHEA Conference was held at the Hamburg Center for Health Economics (HCHE), 13-16th July 2016. The topic of the meeting was “Know the Ropes - Balancing Costs and Quality in Health Care”. Members of the OHE team attended and contributed to the conference; this post summarises their activity.

“Complementary diagnostics” are defined as tests using biomarkers for risk assessment, diagnosis, prognosis, monitoring, and guiding therapeutic decisions. This White Paper presents a more comprehensive framework for considering their value contribution.

This is part one of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington DC, 20-25th May 2016.

This post contains posters which were presented by members of the OHE team at the 2016 HTAi Annual Meeting held in Tokyo, Japan, 10-14 May.

The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. This post contains presentations given by the OHE team.